Catalyst

Slingshot members are tracking this event:

Agenus (AGEN) Acquires Biologics Manufacturing Facility from XOMA (XOMA), An Exclusive License to a Phage Display Library from IONTAS, and Added Cell Line Development Capabilities in Agreement with Selexis

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
XOMA

100%
AGEN

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 05, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phage Display Library, Antibody Pilot Plant, Ell Line Development Technology